Pharmhouse Corp (PHSE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pharmhouse Corp (PHSE) has a cash flow conversion efficiency ratio of -0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-574.03K) by net assets ($54.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pharmhouse Corp net asset quality index to measure how much of total assets are equity-financed.
Pharmhouse Corp - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Pharmhouse Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PHSE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Pharmhouse Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmhouse Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Demco Public Company Limited
BK:DEMCO
|
0.015x |
|
Jung Shing Wire Co Ltd
TW:1617
|
-0.018x |
|
Columbus Acquisition Corp Ordinary Shares
NASDAQ:COLA
|
-0.002x |
|
Berjaya Food Bhd
KLSE:5196
|
-0.045x |
|
Kootenay Silver Inc
V:KTN
|
-0.025x |
|
Canagold Resources Ltd
TO:CCM
|
-0.006x |
|
Holland Colours NV
AS:HOLCO
|
-0.010x |
|
Dagi Giyim Sanayi ve Ticaret AS
IS:DAGI
|
0.174x |
Annual Cash Flow Conversion Efficiency for Pharmhouse Corp (1996–2025)
The table below shows the annual cash flow conversion efficiency of Pharmhouse Corp from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see PHSE market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $52.30 Million | $-2.49 Million | -0.048x | -107.78% |
| 2024-12-31 | $-1.00 Million | $-614.75K | 0.612x | +108.47% |
| 2023-12-31 | $-236.54K | $1.71 Million | -7.229x | -65709.72% |
| 2021-12-31 | $6.47 Million | $-71.12K | -0.011x | +96.42% |
| 2020-12-31 | $6.36 Million | $-1.95 Million | -0.307x | -827.23% |
| 2019-12-31 | $-19.68K | $652.00 | -0.033x | +99.02% |
| 1998-12-31 | $570.54K | $-1.93 Million | -3.377x | -553.85% |
| 1997-12-31 | $3.54 Million | $-1.83 Million | -0.517x | -35.81% |
| 1996-12-31 | $6.41 Million | $-2.44 Million | -0.380x | -- |
About Pharmhouse Corp
Pride Holdings Group operates as a LGBTQ-focused entertainment, hospitality, and lifestyle company in the United States. It engages in the bar, pub, tavern, restaurant, hotels, nightclubs, and live adult entertainment industry businesses. The company was formerly known as Parliament House Enterprises, Inc. and changed its name to Pride Holdings Group in July 2025. Pride Holdings Group is based in… Read more